Valor pronóstico del índice de Charlson en la mortalidad en pacientes con embolia pulmonar asociada a cáncer frente a embolia pulmonar no tumoral

De Miguel-Diez, 2020, Changing trends in hospital admissions for pulmonary embolism in Spain from 2001 to 2018, J Clin Med., 9, 3221, 10.3390/jcm9103221 De Miguel-Diez, 2014, Trends in hospital admissions for pulmonary embolism in Spain from 2002 to 2011, Eur Respir J., 44, 942, 10.1183/09031936.00194213 Chan, 2020, Pulmonary embolism: Clinical presentation and diagnosis in the oldest old, Intern Med J., 50, 627, 10.1111/imj.14824 Khorana, 2007, Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy, J Thromb Haemost., 5, 632, 10.1111/j.1538-7836.2007.02374.x Prandoni, 2005, Cancer and venous thromboembolism, Lancet Oncol, 6, 401, 10.1016/S1470-2045(05)70207-2 Sallah, 2002, Venous thrombosis in patients with solid tumors: Determination of frequency and characteristics, Thromb Haemost., 87, 575, 10.1055/s-0037-1613051 Heit, 2002, Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: A population-based study, Arch Intern Med., 162, 1245, 10.1001/archinte.162.11.1245 Ng, 2011, Long-term cardiovascular and noncardiovascular mortality of 1023 patients with confirmed acute pulmonary embolism, Circ Cardiovasc Qual Outcomes., 4, 122, 10.1161/CIRCOUTCOMES.110.958397 Lee, 2009, Clinical course of pulmonary embolism in lung cancer patients, Respiration., 78, 42, 10.1159/000176208 Quan, 2011, Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries, Am J Epidemiol., 173, 676, 10.1093/aje/kwq433 Zhou, 2020, [Risk factors associated with mortality in patient with non-high-risk pulmonary embolism and cancer and the prognostic value of Charlson comorbidity index] Chinese, Zhonghua Yi Xue Za Zhi., 100, 2383 Friz, 2020, Predictors of medium- and long-term mortality in elderly patients with acute pulmonary embolism, Heliyon., 6, e04857, 10.1016/j.heliyon.2020.e04857 Friz, 2017, Comorbidity assessment as predictor of short and long-term mortality in elderly patients with hemodynamically stable acute pulmonary embolism, J Thromb Thrombolysis., 44, 316, 10.1007/s11239-017-1540-y Ng, 2013, Prognostic impact of the Charlson comorbidity index on mortality following acute pulmonary embolism, Respiration., 85, 408, 10.1159/000342024 Golpe, 2013, Prognostic value of the Charlson comorbidity index in pulmonary embolism, Respiration., 85, 438, 10.1159/000346982 Zhou, 2016, [Risk factors associated with long-term mortality in patients with pulmonary embolism and the predictive value of Charlson comorbidity index] Chinese, Zhonghua Yi Xue Za Zhi., 96, 273 Uresandi, 2013, National consensus on the diagnosis, risk stratification and treatment of patients with pulmonary embolism, Arch Bronconeumol., 49, 534, 10.1016/j.arbres.2013.07.008 Konstantinides, 2015, Guía de práctica clínica de la ESC 2014 sobre el diagnóstico y el tratamiento de la embolia pulmonar aguda, Rev Esp Cardiol., 68, 64.e1, 10.1016/j.recesp.2014.12.002 Ahn, 2017, Prognostic value of treatment setting in patients with cancer having pulmonary embolism: Comparison with the pulmonary embolism severity index, Clin Appl Thromb Hemost., 23, 615, 10.1177/1076029615625826 Pruthi, 2013, Review of the American College of Chest Physicians 2012 guidelines for anticoagulation therapy and prevention of thrombosis, Semin Hematol., 50, 251, 10.1053/j.seminhematol.2013.06.005 Tafur, 2018, Predictors of early mortality in cancer-associated thrombosis: Analysis of the RIETE database, TH Open., 2, e158, 10.1055/s-0038-1642022 Konstantinides, 2020, 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS), Eur Heart J, 41, 543, 10.1093/eurheartj/ehz405